Lifeward Ltd.LFWD
Price (close)
$6.97
Market cap
$19.7M
P/E
—
Revenue (TTM)
$21.8M
Net income
-$30.8M
Dividend yield
—
1-year total return
-25.7%
Net margin
-141.3%
Revenue growth
-10.7%
Debt / equity
—
What Lifeward Ltd. does.
are a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical
rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community.
Our initial product offerings were the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices for individuals with spinal cord
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.4M | $6.0M | $5.5M | $13.9M | $25.7M | $22.0M |
| Net income | -$13.0M | -$12.7M | -$19.6M | -$22.1M | -$28.9M | -$19.9M |
| Free cash flow | -$12.7M | -$11.5M | -$17.9M | -$20.7M | -$21.7M | -$16.8M |
More on LFWD.
- Lifeward Ltd. summary
- Lifeward Ltd. financial statements
- Lifeward Ltd. key metrics
- Lifeward Ltd. health scores and style box
- Lifeward Ltd. earnings
- Lifeward Ltd. dividends
- Lifeward Ltd. valuation
- Lifeward Ltd. ownership and insiders
- Lifeward Ltd. peers
Figures from Lifeward Ltd.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.